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INTRODUCTION 
 
Acute pancreatitis 
Acute pancreatitis is an inflammatory disease caused 
by the premature activation of pancreatic exocrine enzymes 
which leads to the injury of the gland and other organs. 
Approximately 3000 patients develop acute pancreatitis 
annually in Hungary. Alcohol and gallstones are the etiological 
factors in almost 80% of the cases, but several other factors are 
believed to be important in the initiation of the inflammatory 
cascade.  
The clinical classification into mild and severe forms 
has prognostic relevance. Mild edematous pancreatitis is 
considered to be a self-limiting disease with low complication 
rate and it can be treated in most patients by fasting. In contrast 
to this, the mortality of the severe necro-hemorrhagic form 
(10-20%) is still high and except biliary pancreatitis it does not 
have a specific therapy. 
 
Pathogenesis of acute pancreatitis 
The molecular background of the pathogenesis of 
acute pancreatitis is still not fully understood. Intracellular 
activation of the exocrine enzymes is believed to be the key 
step in the development of the disease. The best established 
theory pronounces the central role of the fusion of zymogen 
granules and lysosomes as the result of a secretory blockade 
caused by cholecystokinin (CCK) hyperstimulation. In the 
formed autophag vacuole the lysosomal enzyme cathespsin B 
can activate the pancreatic trypsinogen. Auto-activation of 
trypsinogen which is facilitated by an acidic pH and high 
calcium concentration is another possible mechanism.  
As activated enzymes can enter the systemic 
circulation and injure the tissue of the lung and other organs, 
local pancreatic changes can be accompanied by systemic 
alternations.  
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Trypsin can activate the complement system a thereby 
lead to the production of chemotactic complement factors 
(C3a, C5a). These factors attract macrophages and neutrophils 
to the tissue which produce further cytokines. The released 
tumor necrisis factor-alpha (TNF-α), interleukin-1 (IL), IL-6, 
nitric oxide and platelet activating factor can amplify the 
inflammatory response. Pancreatic acinar cells and infiltrating 
leucocytes can produces oxygen and nitrogen derived free 
radicals (FR) which can damage the lipid membranes of the 
cell. Lipid peroxidation is leading to the increased permeability 
of the membranes and finally to cell death. In the early phase 
of pancreatitis FRs are responsible for edema formation. 
Tissue edema and also systemic stress results in the slow down 
of pancreatic microcirculation and as a consequence of this it 
leads to formation of thrombi which causes the hypoxia and 
necrosis of the tissue. This is probably the reason for the 
conversion of mild edematous pancreatitis to necrohemorragic 
pancreatitis. 
In the investigations of inflammatory processes, 
attention has recently turned to the activation of the 
transcription factor nuclear factor kappa B (NF-κB). NF-κB 
binding elements have been found in the promoter region of 
many genes encoding TNF-alpha, IL-1 and 6, inducible nitric 
oxide synthase (iNOS), cyclooxigenase-2 (COX-2) and many 
other cytokines and enzymes. In the pancreas, NF-κB exists as 
a homo or heterodimer of two subunits called p65 and p50. 
Under physiological conditions, NF-κB is located in the 
cytosol of the cell and is bound to the inhibitory protein I-
kappaB (I-κB). During the inflammatory processes, I-κB is 
phosphorylated by I-κB kinase and becomes the target of 
degradation, and the unbound NF-κB can translocate to the 
nuclei. NF-κB is believed to be a key factor in the development 
of acute pancreatitis. Inhibition of NF-κB activation has been 
shown to exert anti-inflammatory effects in acute pancreatitis.  
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Experimental pancreatitis 
 The pathomechanism and especially the early events of 
acute pancreatitis can not be sufficiently studied in clinical 
settings; therefore several experimental models were 
developed for the induction of pancreatitis in different species 
and with varying severity. Mild edematous pancreatitis can be 
induced in rodents by the administration of secretagogues like 
CCK-octapeptide (CCK-8) or cerulein or by ligation of the 
pancreatic duct. Acute necrotizing pancreatitis can be evoked 
by the retrograde injection of taurocholic acid to the 
biliopancreatic duct, by intraperitoneal injections of L-arginine 
or in mice by a choline-deficient ethionine-supplemented diet. 
The lethality of these models is high. The CCK-8 and the L-
arginine-induced pancreatitis models were used in our 
experiments to evoke edematous or necrotizing pancreatitis 
respectively. These models are simple, highly reproducible and 
the severity of the illness is dose dependent.  
 
Antioxidant or anti-inflammatory drugs in the treatment of 
experimental pancreatitis. 
 Several antioxidant drugs were applied in the therapy 
of acute experimental pancreatitis in the past. These substances 
were able to influence some parameters of acute pancreatitis 
but clinically they were not efficient enough to reduce the 
severity of human pancreatitis. Therefore our attention was 
turned to substances which can target a broader spectrum of 
pathological mechanisms.  
 
Melatonin 
The pineal product melatonin is known to play a role in 
the regulation of the circadian rhythm. The antioxidant activity 
of melatonin has recently received significant attention. The 
protective effects of melatonin have been documented in 
experimental models of numerous diseases like stroke, 
Alzheimer, Parkinson and Huntington diseases, fetal brain 
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injury, hypoxia/reperfusion-induced heart, liver, retina and gut 
injuries, endotoxic and circulatory shock. 
Melatonin exerts its antioxidant effects by directly 
detoxifying free radicals, influencing the activity of scavenger 
enzymes like glutathione peroxidase (GPx), superoxide 
dismutase (SOD) and catalase (CAT) and by inhibiting the 
activity of NOS. Moreover, melatonin can inhibit the 
activation of NF-κB, thereby it reduces the synthesis of 
inflammatory cytokines such as IL-6 and TNF-α. 
In an earlier study, Qi and colleagues showed that in 
mild, cerulein-induced edematous pancreatitis pharmacological 
doses of melatonin protected against the injury caused by FRs. 
Melatonin decreased the edema in the pancreas and stomach, 
and also the extent of lipid peroxidation in the pancreas. 
Jaworek et al. demonstrated that even the circadian changes in 
the physiological levels of melatonin reduced the severity of 
experimental pancreatitis. The protective effect of melatonin in 
severe L-Arg-induced pancreatitis has not been investigated to 
date 
 
Resveratrol 
Resveratrol (trans-3,5,4'-trihydroxystilbene), a 
naturally occurring phytoalexin, is found in numerous plants 
such as grapes, peanuts and soya beans, and it can reach 
especially high concentrations in red wine. Plants produce 
resveratrol in response to fungal infections or UV irradiation. 
Resveratrol had long been used in the traditional Chinese 
medicine as a drug against inflammation, allergy and 
hyperlipidemia before its beneficial effect was proven in 
experimental settings. It exerts antioxidant, anti-inflammatory 
and also anti-cancer effects in various organs like heart, brain, 
lung and intestines. The protective properties of resveratrol 
observed in vitro and in vivo and the high amount of it present 
in red wine had led some scientists to believe that this is the 
substance responsible for the “French paradox”: the 
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phenomenon that the frequent consumption of red wine in 
France is associated with a reduced mortality due to coronary 
heart disease and cancer as compared with other European 
countries. 
 The molecular background of the effects of resveratrol 
appears to be its ability to eliminate hydroxyl, superoxide and 
metal-induced radicals and thereby protect the lipid 
membranes of the cell against the lipid peroxidation otherwise 
caused by these radicals. The suppression of COX-2 and iNOS 
activities also contributes to its anti-inflammatory and 
antioxidant effects. Resveratrol additionally inhibits platelet 
aggregation and endothelial activation, and blocks all three 
phases of tumor development including initiation, promotion 
and progression. Resveratrol blocks the activity of I-κB kinase, 
thereby inhibiting the activation of NF-κB and the production 
of inflammatory cytokines. Our experiment investigated the 
protective effects of resveratrol pretreatment in acute CCK-8-
induced experimental pancreatitis. 
 
Zerumbone 
Zerumbone (2,6,9,9-tetramethylcycloundeca-2,6,10-
trien-1-one) is a sesquiterpenoid found in large amounts in the 
rhizome of Zingiber zerumbet, a plant traditionally used as a 
condiment. In the South-east Asian countries Zingiber 
zerumbet is used for the treatment of swellings, sores, loss of 
appetite, worm infestation, toothache and indigestion. 
Sesquiterpenes such as zerumbone isolated from this plant also 
possess anti-allergenic and anti-spasmodic properties. Only 
few literary data exist about the molecular effects of 
zerumbone. However in vitro experiments with zerumbone 
have demonstrated a number of beneficial effects of the drug. 
Most of these studies were focused on the chemopreventive 
and chemotherapeutic effects of zerumbone in tumor cell lines. 
Further in vitro experiments have shown that zerumbone 
inhibits the activation of Nf-κB and also the de novo synthesis 
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of iNOS and COX-2. Intrinsic antioxidant properties of 
zerumbone are believed to contribute to its anti-tumor action.  
 The in vivo effects of the compound on diseases 
associated with inflammation and oxidative stress are not well 
described. The in vivo study by Somchit et al showed that an 
extract of Zingiber zerumbet reduces the extent of 
experimentally induced hind paw edema in rats. Murakami et 
al. detected the beneficial effects of the substance in vivo in a 
model of dextran sulfate-induced colitis in mice. Prolonged 
oral administration of the drug reduced the levels of IL-1β, 
TNF-α and prostaglandin E2 in the colonic mucosa of the 
animals and reduced the extent of histological damage to the 
tissue. To date, the influence of zerumbone on the severity of 
pancreatitis has not been investigated. As transcription factor 
Nf-κB, mediators such as IL-6 and TNF-α and also enzymes 
such as iNOS and COX-2 play important roles in the 
development of acute pancreatitis, the drug is a promising 
candidate for the prevention or treatment of acute pancreatitis. 
Therefore we intended to detect the effects of zerumbone in 
CCK-8-induced experimental pancreatitis. 
 
Aims 
The aim of this study is to enlarge our knowledge 
about the pharmacological action of melatonin, resveratrol and 
zerumbone, three natural substances with antioxidant and anti-
inflammatory features, and particularly to investigate the 
impact of these substances on the severity of acute 
experimental pancreatitis. 
 
METHODS 
Animals 
 Male Wistar rats weighing (200-300g) were used in 
our experiments. Tissue samples were collected from the 
animals after exsanguinations in pentobarbital anesthesia. The 
samples were quickly removed and frozen at -70°C until 
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use.These studies were approved by the Ethical Committee on 
Animal Experiments of the University of Szeged, in 
accordance with ethical standards as formulated in the Helsinki 
Declaration of 1975 (revised 1983). 
 
Protocol of the melatonin study 
Rats were divided into five groups (n=5 per group). In 
group A, pancreatitis was induced with 3.2 g/kg body weight 
L-Arg i.p. twice at an interval of 1 h. Rats in group MA were 
treated with a single dose of 50 mg/kg body weight melatonin 
i.p. 30 min prior to L-Arg administration. Rats of group AM 
received the same dose of melatonin 1 h after the second 
injection of L-Arg. In group M, a single dose of melatonin was 
administered. The rats in group C served as control animals 
and received i.p. injections of physiological saline.  
 
Protocol of the resveratrol study 
Rats were divided into three groups (n=5 in each group). 
The rats in group RP were treated with a single dose of 
10 mg/kg body weight resveratrol i.p. 30 min prior to the 
induction of pancreatitis by three s.c. injections of 75 µg/kg 
CCK-8 at intervals of 1 h. In group P, the rats received an 
injection of physiological saline instead of resveratrol, 
followed by the three CCK-8 injections. The rats in group C 
served as control animals and received one i.p. and three s.c. 
injections of physiological saline.  
 
Protocol of the zerumbone study 
Rats were divided into four. The rats in group ZP were 
treated i.p. with a single dose of 20 mg/kg zerumbone 30 min 
prior to the induction of pancreatitis by three s.c. injections of 
100 µg/kg CCK-8 at intervals of 1 h (n=10). In group P, the 
rats received an injection of DMSO (vehicle) instead of 
zerumbone, followed by the three CCK-8 injections (n=10). 
The rats in group Z were treated i.p. with a single injection of 
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20 mg/kg zerumbone followed by three s.c. injections of 
physiological saline (n=5). The rats in group C served as 
control animals and received one i.p. and three s.c. injections 
of physiological saline (n=5).  
 
Assays  
The pancreatic weight/body weight ratio was evaluated 
as an estimate of the degree of pancreatic edema. The serum 
amylase, lipase and aspartate aminotransferase (ASAT) 
activities, and the triglyceride, creatinine, urea nitrogen, 
calcium and glucose concentrations were determined by 
colorimetric methods (Dialab, Vienna, Austria, and FaBio, 
Hungary). The concentration of the lipid peroxidation marker 
malonyl dialdehyde (MDA) was measured as described by 
Placer. Total SOD activity was determined on the basis of the 
inhibition of epinephrine-adenochrome autoxidation. Mn-SOD 
activity was measured via the extent of autoxidation in the 
presence of 5 x 10-3 M KCN. The Cu/Zn-SOD activity was 
obtained by deducting the Mn-SOD activity from the total 
SOD activity. CAT activity was determined 
spectrophotometrically at 240 nm and expressed in Bergmeyer 
units. GPx activity was determined using cumene 
hydroperoxide and reduced glutathione (GSH) as substrates of 
GPx. Total GSH was measured spectrophotometrically with 
Ellman’s reagent. The degree of leukocyte infiltration was 
quantified by the measurement of pancreatic myeloperoxidase 
(MPO) activity. The activities of iNOS and cNOS, were 
determined by the method described by Knowles and Salter. 
For the evaluation of pancreatic TNF-α IL-6 concentrations, 
tissues were homogenized by the method of Dignam et al  and 
measured with an Enzyme-Linked Immunosorbent Assay kit 
according to the manufacturer’s instructions and corrected for 
the protein content of the tissue. The protein concentration of 
the tissues was determined by the method of Goa. A 
histological investigation was performed on hematoxylin and 
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eosin stained slices. The nuclear translocation of the P65 
subunit of NF-κB was investigated by immunohistochemistry, 
according to the manufacturer’s instruction. 
The I-κB concentration of the cytosol fraction was 
measured in after homogenization by Western blot according 
to the method of Laemmli.  
 
Statistical analysis 
One-way analysis of variance (ANOVA) and a least 
significant difference (Fisher’s LSD) post hoc analysis were 
performed to test for significant differences between the three 
experimental groups. P<0.05 was accepted as indicating a 
statistically significant difference. 
 
RESULTS 
Melatonin 
 Histological investigation confirmed the development 
of severe necrotizing pancreatitis in all rats given L-Arg, with 
no discernible differences between the groups. Melatonin pre-
treatment failed to influence the pancreas weight/body weight 
ratio, the serum amylase and the pancreatic SOD activity, but it 
significantly reduced the pancreatic CAT activity, the hepatic 
CAT and Cu/Zn-SOD activities as compared with group A and 
prevented the significant elevation of hepatic GPx activity and 
pancreatic MDA, MPO and IL-6 content and the reduction of 
hepatic Mn-SOD activity. Melatonin post-treatment 
significantly reduced the serum amylase activity versus group 
A and ameliorated the changes of hepatic MDA, Mn-SOD, 
Cu/Zn-SOD activities and the pancreatic MPO and IL-6 
content. 
 
Resveratrol 
 The development of edematous pancreatitis in the 
CCK-8-treated animals was confirmed by histology. 
Resveratrol significantly reduced the edema and acinar 
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necrosis in the pancreas, it reduced the elevation of pancreatic 
weight/body weight ratio and serum amylase and lipase 
activities and ameliorated the changes of serum glucose, 
calcium, ASAT and creatinine levels relative to group P. 
Resveratrol pretreatment could not influence the reduction of 
the Cu/Zn-SOD and GPx activities in the pancreas. 
Administration of resveratrol in group RP significantly 
increased the amount of GSH in the liver vs. group C and P, 
and prevented the significant reduction of CAT activity 
compared to group C. The immuno-histochemistry of the 
pancreas revealed increased numbers of P65 nuclear-positive 
cells in groups P and RP versus group C, but there was no 
significant difference in nuclear staining between groups RP 
and P. 
 
Zerumbone 
 The development of acute pancreatitis was confirmed 
by the significant elevation of the pancreatic weight/body 
weight ratio, serum amylase and lipase activities in group P 
and RP vs group C, but the histology revealed only slight 
changes referring to the mildness of edematous pancreatitis. 
Zerumbone treatment significantly reduced the elevation of 
pancreatic weight/body weight ratio, serum amylase and lipase 
activities but it failed to influence the histology and increased 
the concentration of ASAT versus group C and P. Zerumbone 
pretreatment significantly reduced the changes of pancreatic 
iNOS, cNOS, Mn-SOD and Cu/Zn-SOD activities and reduced 
the elevation of pancreatic TNF-α and IL-6 concentrations The 
amount of cytosolic I-κB was significantly reduced in group P, 
but not in group ZP, as compared with group C. The pancreatic 
I-κB content in group Z was significantly higher than in group 
C. 
 
CONCLUSION 
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The aim of our work was to demonstrate the effects of 
three substances on the development of acute experimental 
pancreatitis. The common features of these drugs, namely 
melatonin, resveratrol and zerumbone are their antioxidant 
properties and their ability to exert anti-inflammatory effects. 
The source of the three natural substances is different.  
Melatonin is a pineal hormone present in the human organism, 
whereas resveratrol and zerumbone are found in plants that can 
be the constituents of our diet. Melatonin is available as a drug 
against jet-lag or depression, whereas resveratrol is used in the 
herbal medicine as a prophylactic drug against cardiovascular 
diseases. Zerumbone is a recently isolated substance and its in 
vivo effects are poorly described, therefore the medical use of 
the pure isolated drug requires further investigations. However 
Zingiber zerumbet, the main source of zerumbone and also 
resveratrol have long been used in the traditional Southeast 
Asian or Chinese medicine as anti-inflammatory drugs.  
Our experiments demonstrated the beneficial effects of these 
compounds in experimental pancreatitis. Because the 
protective abilities of melatonin were already examined in mild 
edematous pancreatitis, our aim was to investigate the effects 
of the drug in the L-arginine-induced necrotizing pancreatitis 
model. Our study showed that melatonin is potent enough to 
influence some of the parameters of L-arginine-induced 
pancreatitis; however the histological changes were not 
mitigated by the drug. The principle observation was the 
hepato-protective effect of melatonin pretreatment. The basal 
activities of the scavenger enzymes are 10-fold higher in the 
liver than in the pancreas, the influence of melatonin on the 
scavenger enzyme activities can therefore predominate in this 
tissue. The low pancreatic scavenger activities are probably 
one reason for the high mortality associated with acute 
pancreatitis.  
The effects of resveratrol on acute pancreatitis were 
not described by others at the time our study was carried out. 
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Therefore we choused the CCK-8-induced pancreatitis model 
and examined the effects of resveratrol pretreatment in this 
model. Our findings demonstrated the antioxidant effects of 
resveratrol in the liver, the considerable beneficial effect of the 
drug on the serum parameters of pancreatitis and the 
histological protection due to resveratrol pretreatment. 
Meanwhile Meng et al. demonstrated the beneficial effect of 
resveratrol in taurocholate-induced necrotizing pancreatitis and 
Lawinski et al. reported the antioxidant effect of resveratrol in 
tert-butyl-hydroperoxide-induced pancreatitis. In contrast to 
the results of Meng et al inhibition of NF-kappa B activation 
could not been detected in our study.  
We were the first to detect the positive effects of 
zerumbone in acute experimental pancreatitis. The substance 
has not been used earlier in the therapy of experimental 
pancreatitis and only few literary data exist about the in vivo 
effects of the drug. Therefore we decided to investigate the 
efficacy of zerumbone pretreatment in CCK-8-induced 
pancreatitis to decide if the compound is a promising candidate 
for further studies in the field of acute pancreatitis. Our results 
clearly demonstrated the antioxidant and anti-inflammatory 
effects of zerumbone in acute pancreatitis, however a 
beneficial effect of the drug on the histological scores was not 
detected. Inhibition of I-kappaB degradation by zerumbone 
refers to the NF-kappaB inhibitory effect of the drug, being 
probably the key mechanism of the action of zerumbone. 
 
NEW FINDINGS 
I. Compared to previous publications where melatonin 
protected against mild edematous pancreatitis, our 
results showed that in severe acute necrotizing 
pancreatitis this substance can exert only moderate 
protective effects. The antioxidant effects of melatonin 
predominate in the liver tissue. 
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II. The beneficial effect of resveratrol pretreatment on 
CCK-8-induced acute pancreatitis was clearly 
demonstrated in our study. The substance significantly 
attenuated the serum parameters of acute pancreatitis, 
reduced the histological damage of the pancreatic 
tissue and improved the antioxidant state of the liver, 
without influencing the activation of NF-kappaB. 
III. Zerumbone pretreatment was shown to express its 
anti-inflammatory and antioxidant effects in the 
pancreas of animals with CCK-8-induced acute 
pancreatitis. The background of the observed 
beneficial effects is probably the inhibition of NF-
kappaB activation.  
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